Efficacy and therapeutic potential of plant sterols

Atherosclerosis Supplements

Volumn 3, Issue 3, 2002, Pages 11-15

  Neil, H A W ^a   Huxley, R R ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; SITOSTANOL; HYPOCHOLESTEROLEMIC AGENT;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; DIET THERAPY; DIETARY INTAKE; DISEASE SEVERITY; FAMILIAL HYPERCHOLESTEROLEMIA; FOOD COMPOSITION; FOOD INTAKE; HUMAN; HYDROGENATION; HYPERCHOLESTEROLEMIA; INTESTINE ABSORPTION; ISCHEMIC HEART DISEASE; MICELLE; PATIENT; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; RISK REDUCTION; SAFETY; BLOOD; DIET;

ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; DIET; HUMANS; HYPERCHOLESTEROLEMIA; PHYTOSTEROLS;

EID: 0036782439     PISSN: 15675688     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1567-5688(02)00021-1     Document Type: Article

References (38)

1. Pollak O.J., Kritchevsky D. Monographs in Atherosclerosis. 1981;Basel, New York.
2. Ling W.H., Jones P.J.H. Minireview dietary phytosterols: a review of metabolism, benefits and side effects. Life Sci. 57:1995;195-206.
3. Jones P.J.H., MacDougall D.E., Ntanios F., Vanstone C.A. Dietary phytosterols as cholesterol-lowering agents in humans. Can. J. Physiol. Pharmacol. 75:1997;217-227.
4. Tang J.-L., Armitage J., Silagy C., Lancaster T., Fowler G.H., Neil H.A.W. Systematic review of dietary intervention trials to lower cholesterol in free-living individuals. Br. Med. J. 316:1998;1215-1219.
5. Law M. Plant sterol and stanol margarines and health. Br. Med. J. 320:2000;861-864.
6. Hallikainen M.A., Sarkkinen E.S., Gylling H., Erkkila A.T., Uusitupa M.I.J. Comparison of the effects of plant sterol ester and plant stanol ester-enriched margarines in lowering serum cholesterol concentrations in hypercholesterolaemic subjects on a low fat diet. Eur. J. Clin. Nutr. 54:2000;767-776.
7. Jones P.J., Raeini-Sarjaz M., Ntanios F.Y., Vanstone C.A., Feng J.Y., Parsons W.E. Modulation of plasma lipid levels and cholesterol kinetics by phytosterol versus phytonstanol esters. J. Lipid Res. 41:2000;697-705.
8. Amundsen AG, Oxe L, Nenseter MS, Ntanios F. Plant sterol-enriched spread lowers plasma total- and LDL-cholesterol in children with familial hypercholesterolaemia, Am. J. Clin. Nutr. 2002 (in press).
9. Nigon F., Serfaty-Lacrosniètr, Beucler I., Chauvois D., Neveu C., Giral P., Chapman M.J., Bruckert E. Plant sterol-enriched margarine lowers plasma LDL in hyperlipidaemia subjects with low cholesterol intake: effect of fibrate treatment. Clin Chem. Lab. Med. 39:2001;634-640.
10. Neil H.A.W., Meijer G.W., Roe L.S. Randomised controlled trial of use by hypercholesterolaemic patients of a vegetable oil sterol-enriched fat spread. Atherosclerosis. 156:2001;329-337.
11. Noakes M., Clifton P.M., Ntanios F., Schrapnel W., Record I., McInerney J. An increase in dietary carotenoids when consuming plant sterols or stanols is effective in maintaining plasma carotenoid levels. Am. J. Clin. Nutr. 75:2002;79-86.
12. Hendriks H.F., Weststrate J.A., van Vliet T., Meijer G.W. Spreads enriched with three different levels of vegetable oil sterols and the degree of cholesterol lowering in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 53:1999;319-327.
13. Volpe R., Niittynen L., Korpela R., Sirtori C., Bucci A., Fraone N., Pazzucconi F. Effects of yoghurt enriched with plant sterols on serum lipids in patients with moderate hypercholesterolaemia. Br. J. Nutr. 86:2001;233-239.
14. Maki K.C., Davidson M.H., Umporowicz D.M., Schaefer E.J., Dicklin M.R., Ingram K.A., Chen S., McNamara J.R., Gebhart B.W., Ribaya-Mercado J.D., Perrone G., Robins S.J., Franke W.C. Lipid responses to plant-sterol-enriched reduced-fat spreads incorporated into a National Cholesterol Education Program Step I diet. Am. J. Clin. Nutr. 74:2001;33-43.
15. Goldstein J.L., Hobbs H.H., Brown M.S. Familial Hypercholesterolaemia. Scriver C.R., Beaudet A.L., Sly W.S., Valle D. The Metabolic and Molecular Basis of Inherited Disorders. seventh ed. 1995;1981-2030 McGraw Hill, New York.
16. Slack J. Risks of ischaemic heart disease in familial hyperlipidaemic states. Lancet. 2:1969;1380-1382.
17. Stone N.J., Levy R.I., Fredrickson D.S., Verter J. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinaemia. Circulation. 49:1974;476-488.
18. Scientific Steering Committee on behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 1999;142:105-112.
19. Jones P., Kafonek S., Laurona I., Hunninghake D. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolaemia (The Curves Study). Am. J. Cardiol. 81:1998;582-587.
20. Shepherd J., Cobbe S.M., Ford I., Isles C., Lorimer A.R., MacFarlane P.W., et al. Prevention of coronary heart disease in men with hypercholesterolaemia. New Engl. J. Med. 333:1995;1301-1307.
21. Downs J.R., Clearfield M., Weis S., Whitney E., Shapiro D.R., Beere P.A., et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels. J. Am. Med. Assoc. 279:1998;1615-1622.
22. Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-89.
23. Sacks F.M., Peffer M.A., Moye L.A., Rouleau J.L., Rutherford J.D., Cole T.G., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. New Engl. J. Med. 335:1996;1001-1009.
24. LIPID Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial levels. New Engl. J. Med. 1998;339:1349-57.
25. Smilde T.J., van Wissen S., Wollersheim H., Trip M.D., Kasteleiin J.J.P., Stalenhoef A.F.H. Effect of aggressive versus conventional lipid lowering on atherosclerosis progression in familial hypercholesterolaemia (ASAP): a prospective randomised controlled trial. Lancet. 357:2001;577-581.
26. Gylling H., Siimes M.A., Miettinen T.A. Sitostanol ester margarine in dietary treatment of children with familial hypercholesterolaemia. J. Lipid. Res. 36:1995;1807-1812.
27. Gylling H., Puska P., Vartiainen E., Miettinen T.A. Retinol, vitamin D, carotenes and alpha-tocopherol in serum of a moderately hypercholesterolaemic population consuming sitostanol margarine. Atherosclerosis. 145:1999;279-285.
28. Illingworth D.R. Drug therapy for hyperlipidaemia in childhood. Neil A., Rees A., Taylor C. Hyperlipidaemia in Childhood. 1996;51-65 Royal College of Physician, London.
29. Lutjohann D., von Bergmann K. Phytosterolaemia: diagnosis, characterisation and therapeutic approaches. Ann. Med. 29:1997;181-184.
30. Gylling H., Radhakrishnan R., Miettinen T.A. Reduction in serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine. Circulation. 96:1997;4226-4231.
31. Gylling H., Miettinen T.A. Effects of inhibiting cholesterol absorption and synthesis on cholesterol and lipoprotein metabolism in hypercholesterolaemic non-insulin-dependent men. J. Lipid Res. 37:1996;1776-1785.
32. Blari S.N., Capuzzi D.M., Gottlieb S.O., Nguyen T., Morgan J.M., Cater N.B. Incremental reduction in total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy. Am. J. Cardiol. 86:2000;46-52.
33. Kesaniemi Y.A., Ehnholm C., Miettinen T.A. Intestinal cholesterol absorption efficacy in man is related to apoprotein E phenotype. J. Clin. Invest. 80:1987;578-581.
34. Naoumova R.P., Marais A.D., Mountney, Firth J.C., Rendell N.B., Taylor G.W., et al. Plasma mevalonic acid, an index of cholesterol synthesis in vivo, and responsiveness to HMG-CoA reductase inhibitors in familial hypercholesterolaemia. Atherosclerosis. 119:1996;203-213.
35. Miettinen TA, Gylling H, Strandberg T, Sarna S. for the Finnish 4S Investigators. Baseline serum cholestanol as predictor of recurrent coronary events in subgroup of Scandinavian simvastatin survival study, Br. Med. J. 1998;316:1127-30.
36. Weststrate J.A., Meijer G.W. Plant sterol-enriched margarines and reduction of plasma total and LDL-cholesterol concentrations in normocholesterolaemic and mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 52:1998;334-343.
37. Miettinen T.A., Puska P., Gylling H., Vanhanen H., Vartianen E. Reduction of serum cholesterol with sitostanol-ester margarine in a mildly hypercholesterolaemic population. New Engl. J. Med. 333:1995;1308-1312.
38. Hendriks HFJ, Ntanios FY, Brink EJ, Princen HMG, Buytenhek R, Meijer G. One year follow-up study of a low fat spread enriched with plant sterol-esters. Abstract, International Congress of Nutrition, 2001, Vienna.